Endonovo Therapeutics (OTCMKTS:ENDV) versus Tivic Health Systems (NASDAQ:TIVC) Head-To-Head Comparison

Tivic Health Systems (NASDAQ:TIVCGet Rating) and Endonovo Therapeutics (OTCMKTS:ENDVGet Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent recommendations for Tivic Health Systems and Endonovo Therapeutics, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tivic Health Systems 0 0 0 0 N/A
Endonovo Therapeutics 0 0 0 0 N/A

Insider and Institutional Ownership

0.2% of Tivic Health Systems shares are owned by institutional investors. 14.6% of Tivic Health Systems shares are owned by company insiders. Comparatively, 5.6% of Endonovo Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Tivic Health Systems has a beta of 2.23, suggesting that its stock price is 123% more volatile than the S&P 500. Comparatively, Endonovo Therapeutics has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500.

Valuation and Earnings

This table compares Tivic Health Systems and Endonovo Therapeutics’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tivic Health Systems $1.84 million 1.94 -$10.10 million ($0.93) -0.13
Endonovo Therapeutics $140,000.00 35.13 -$18.48 million N/A N/A

Tivic Health Systems has higher revenue and earnings than Endonovo Therapeutics.


This table compares Tivic Health Systems and Endonovo Therapeutics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Tivic Health Systems -557.41% -174.99% -123.91%
Endonovo Therapeutics -3,988.29% N/A -639.23%


Tivic Health Systems beats Endonovo Therapeutics on 7 of the 9 factors compared between the two stocks.

About Tivic Health Systems

(Get Rating)

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

About Endonovo Therapeutics

(Get Rating)

Endonovo Therapeutics, Inc. is a biotechnology company, which engages in the development, manufacture, and distribution of medical devices focused on the rapid healing of wounds and reduction of pain, edema, and inflammation on and in the human body. Its technology and products include Electroceuticals, EFECT Trial, and SofPulse Electroceutical Therapy. The company was founded in November 2008 and is headquartered in Woodland Hills, CA.

Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.